BullFrog AI Holdings BFRG
NASDAQ BFRG
$0.50 +0.01 (+2.04%)
At close: Sep 4, 2026 · 4:00 PM EDT

BullFrog AI Holdings (BFRG) Net Income towards Common Stockholders (2022 - 2026)

BullFrog AI Holdings' (BFRG) quarterly Net Income towards Common Stockholders came in at -$1.4 million in Q2 2026, up 5.33% on a YoY basis from -$1.3 million in Q2 2025, and up 7.34% quarter-over-quarter from -$1.5 million in Q4 2025.

Analysis

BullFrog AI Holdings (BFRG) Net Income towards Common Stockholders (2022 - 2026) Analysis & Trends

BullFrog AI Holdings (BFRG) has reported Net Income towards Common Stockholders for 5 consecutive years, with -$1.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Net Income towards Common Stockholders rose 5.33% year-over-year to -$1.4 million; the trailing twelve-month figure through Jun 2026 stood at -$5.9 million (up 16.07% YoY), and the FY2025 full-year result was -$6.5 million, up 7.68% from the prior year.
  • Net Income towards Common Stockholders grew to -$1.4 million in Q2 2026 per BFRG's latest filing, from -$1.5 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at -$566740.0 in Q1 2022 and bottomed at -$2.0 million in Q1 2025.
  • Historically, Net Income towards Common Stockholders has averaged -$1.4 million across 5 years, with a median of -$1.4 million in 2025.
  • The sharpest annual moves came in 2023 and 2025: Net Income towards Common Stockholders tumbled 133.89% in 2023, then grew 15.08% in 2025.
  • Over 5 years, Net Income towards Common Stockholders stood at -$695520.0 in 2022, then sank by 86.47% to -$1.3 million in 2023, then sank by 34.39% to -$1.7 million in 2024, then advanced by 15.08% to -$1.5 million in 2025, then grew by 7.34% to -$1.4 million in 2026.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$1.4 million, -$1.5 million, and -$1.6 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 2.38 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn -10.50 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 1.10 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 1.30 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 472.00 Mn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn -782.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 164.49 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 97.50 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn -13.27 Mn
10 BullFrog AI Holdings 9.27 Mn 2.35 Mn 106,899.00 -1.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.37 Mn
Dec 31, 2025 -1.48 Mn
Sep 30, 2025 -1.55 Mn
Jun 30, 2025 -1.45 Mn
Mar 31, 2025 -2.02 Mn
Dec 31, 2024 -1.74 Mn
Sep 30, 2024 -1.76 Mn
Jun 30, 2024 -1.61 Mn
Mar 31, 2024 -1.92 Mn
Dec 31, 2023 -1.30 Mn
Sep 30, 2023 -1.25 Mn
Jun 30, 2023 -1.48 Mn
Mar 31, 2023 -1.33 Mn
Dec 31, 2022 -695,520.00
Sep 30, 2022 -764,711.00
Jun 30, 2022 -775,975.00
Mar 31, 2022 -566,740.00